
Please try another search
Medipal Holdings Corporation engages in the prescription pharmaceutical wholesale business in Japan. It procures healthcare products related to diagnostics, testing, treatment, and administration comprises medical equipment and medical materials, and clinical diagnostic reagents for use from the pre-symptomatic stage; handles PMS services on contract for manufacturers; and invests in orphan drugs and other products. The company is involved in the wholesale of cosmetics, daily necessities, and OTC pharmaceuticals; animal health products for companion animals; food processing raw materials for agriculture, fisheries, and livestock; and livestock feed additives, seasonings, veterinary medical equipment, packaging materials, industrial chemicals, and other products. In addition, it engages in the contract-based epidemiological studies, clinical studies, etc.; creation of a computerized medical supply database and master product databases for medical facilities; life and non-life insurance agency business; cleaning management; management and operation of distribution centers; commissioned delivery and worker dispatch business; and planning, management, administration, and product and service development for the class A health dispensing pharmacies service brand. Further, the company trades in medical clerks; outsourcing of medical administrative, and medical consulting; and distributes specialty pharmaceuticals. Additionally, it engages in contract logistics services, as well as offers information provision services. Medipal Holdings Corporation serves hospitals, clinics, dispensing pharmacies, drugstores, home centers, convenience stores, supermarkets, discount stores, animal hospitals, livestock and fishery businesses, and processed food manufacturers. The company was formerly known as Mediceo Paltac Holdings Co., Ltd. and changed its name to Medipal Holdings Corporation in October 2009. The company was founded in 1898 and is headquartered in Tokyo, Japan.
Name | Age | Since | Title |
---|---|---|---|
Yuji Sakon | - | 2012 | MD, GM of Administration Division & Director |
Toshio Asano | 71 | 2017 | Independent Outside Director |
Shuichi Watanabe | 71 | 2000 | Chief Compliance Officer, CEO, President & Representative Director |
Yasuhiro Choufuku | 69 | 2016 | Executive VP & Director |
Mitsuko Kagami | 65 | 2014 | Independent Outside Director |
Toshihide Yoda | 60 | 2010 | Senior MD of Investor Relations, GM of Business Development Department & Director |
Kuniko Shoji | 69 | 2018 | Independent Outside Director |
Shinjiro Watanabe | 51 | 2013 | GM of Information Systems Management Division & Director |
Imagawa Kuniaki | 62 | 2022 | Director |
Kazuo Hashida | 65 | 2023 | Full-time Corporate Auditor |
Tomoyasu Toyoda | 74 | 2017 | Outside Audit & Supervisory Board Member |
Koichi Mimura | 67 | 2020 | Director |
Hiroshi Iwamoto | 65 | 2021 | Independent Outside Director |
Hatsuyoshi Ichino | 65 | 2023 | Outside Audit & Supervisory Board Member |
Takuya Yoshida | 52 | 2023 | Director |
Imagawa Kuniaki | 63 | 2022 | Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review